RØYRVIK ET AL.22. Bodmer WF. Cancer <strong>genetic</strong>s: colorectal cancer as a model. J Hum Genet.2006;51:391–6.23. Peltomaki P, Aaltonen LA, Sistonen P, Pylkkanen L, Meckl<strong>in</strong> JP, Jarv<strong>in</strong>en H,Green JS, Jass JR, Weber JL, Leach FS, . Genetic mapp<strong>in</strong>g of a locus predispos<strong>in</strong>gto human colorectal cancer. Science. 1993;260(5109):810–2.24. Fishel R, Lescoe MK, Rao MR, Copel<strong>and</strong> NG, Jenk<strong>in</strong>s NA, Garber J, Kane M,Kolodner R. The human mutator gene homolog MSH2 <strong>and</strong> its association withhereditary <strong>no</strong>npolyposis colon cancer. Cell. 1993;75:1027–38.25. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, PeltomakiP, Sistonen P, Aaltonen LA, Nystrom-Lahti M, . Mutations of a mutS homolog<strong>in</strong> hereditary <strong>no</strong>npolyposis colorectal cancer. Cell. 1993;75:1215–25.26. Watson P, Riley B. The tumor spectrum <strong>in</strong> the Lynch syndrome. Fam Cancer.2005;4:245–8.27. Umar A, Bol<strong>and</strong> CR, Terdiman JP, Syngal S, de la CA, Ruschoff J, Fishel R,L<strong>in</strong>dor NM, Burgart LJ, Hamel<strong>in</strong> R, Hamilton SR, Hiatt RA, Jass J, L<strong>in</strong>dblomA, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF,Hawk ET, Barrett JC, Freedman AN, Srivastava S. Revised Bethesda Guidel<strong>in</strong>esfor hereditary <strong>no</strong>npolyposis colorectal cancer (Lynch syndrome) <strong>and</strong> microsatellite<strong>in</strong>stability. J Natl Cancer Inst. 2004;96:261–8.28. de la Chapelle A. Test<strong>in</strong>g tumors for microsatellite <strong>in</strong>stability. Eur J HumGenet. 1999;7:407–8.29. Popat S, Hubner R, Houlston RS. Systematic review of microsatellite <strong>in</strong>stability<strong>and</strong> colorectal cancer prog<strong>no</strong>sis. J Cl<strong>in</strong> Oncol. 2005;20;23:609–18.30. S<strong>in</strong>icrope FA, Rego RL, Hall<strong>in</strong>g KC, Foster N, Sargent DJ, La PB, French AJ,Laurie JA, Goldberg RM, Thibodeau SN, Witzig TE. Prog<strong>no</strong>stic impact of microsatellite<strong>in</strong>stability <strong>and</strong> DNA ploidy <strong>in</strong> human colon carc<strong>in</strong>oma patients.Gastroenterology. 2006;131:729–37.31. Streis<strong>in</strong>ger G, Okada Y, Emrich J, Newton J, Tsugita A, Terzaghi E, I<strong>no</strong>uye M.Frameshift mutations <strong>and</strong> the <strong>genetic</strong> code. Cold Spr<strong>in</strong>g Harb Symp QuantBiol. 1966;31:77–84.32. Kunkel TA. Misalignment-mediated DNA synthesis errors. Biochemistry.1990;29:8003–11.33. Perucho M. Cancer of the microsatellite mutator phe<strong>no</strong>type. Biol Chem. 1996;377:675–84.34. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM,Kolodner R. Methylation of the hMLH1 promoter correlates with lack of expressio<strong>no</strong>f hMLH1 <strong>in</strong> sporadic colon tumors <strong>and</strong> mismatch repair-defectivehuman tumor cell l<strong>in</strong>es. Cancer Res. 1997;57:808–11.244
TARGET GENES OF MSI COLORECTAL CANCER35. Kuismanen SA, Holmberg MT, Salovaara R, de la CA, Peltomaki P. Genetic<strong>and</strong> epi<strong>genetic</strong> modification of MLH1 accounts for a major share of microsatellite-unstablecolorectal cancers. Am J Pathol. 2000;156:1773–9.36. Thibodeau SN, French AJ, Cunn<strong>in</strong>gham JM, Tester D, Burgart LJ, Roche PC,McDonnell SK, Schaid DJ, Vockley CW, Michels VV, Farr GH, Jr., O'ConnellMJ. Microsatellite <strong>in</strong>stability <strong>in</strong> colorectal cancer: different mutator phe<strong>no</strong>types<strong>and</strong> the pr<strong>in</strong>cipal <strong>in</strong>volvement of hMLH1. Cancer Res. 1998;58:1713–8.37. Cunn<strong>in</strong>gham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ,Thibodeau SN. Hypermethylation of the hMLH1 promoter <strong>in</strong> colon cancer withmicrosatellite <strong>in</strong>stability. Cancer Res. 1998;58:3455–60.38. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, Markowitz S,Willson JK, Hamilton SR, K<strong>in</strong>zler KW, Kane MF, Kolodner RD, Vogelste<strong>in</strong> B,Kunkel TA, Bayl<strong>in</strong> SB. Incidence <strong>and</strong> functional consequences of hMLH1promoter hypermethylation <strong>in</strong> colorectal carc<strong>in</strong>oma. Proc Natl Acad Sci U S A.1998;95:6870–5.39. Borresen AL, Lothe RA, Mel<strong>in</strong>g GI, Lystad S, Morrison P, Lipford J, KaneMF, Rognum TO, Kolodner RD. Somatic mutations <strong>in</strong> the hMSH2 gene <strong>in</strong> microsatelliteunstable colorectal carc<strong>in</strong>omas. Hum Mol Genet. 1995;4:2065–72.40. Liu B, Nicolaides NC, Markowitz S, Willson JK, Parsons RE, Jen J, PapadopolousN, Peltomaki P, de la CA, Hamilton SR, . Mismatch repair gene defects<strong>in</strong> sporadic colorectal cancers with microsatellite <strong>in</strong>stability. Nat Genet.1995;9:48–55.41. Jascur T, Bol<strong>and</strong> CR. Structure <strong>and</strong> function of the components of the humanDNA mismatch repair system. Int J Cancer. 2006;119:2030–5.42. Marti TM, Kunz C, Fleck O. DNA mismatch repair <strong>and</strong> mutation avoidancepathways. J Cell Physiol. 2002;191:28–41.43. Hanahan D, We<strong>in</strong>berg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70.44. Kim NG, Rhee H, Li LS, Kim H, Lee JS, Kim JH, Kim NK, Kim H. Identificatio<strong>no</strong>f MARCKS, FLJ11383 <strong>and</strong> TAF1B as putative <strong>no</strong>vel target genes <strong>in</strong> colorectalcarc<strong>in</strong>omas with microsatellite <strong>in</strong>stability. Oncogene. 2002;21:5081–7.45. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS,Zborowska E, K<strong>in</strong>zler KW, Vogelste<strong>in</strong> B, . Inactivation of the type II TGF-betareceptor <strong>in</strong> colon cancer cells with microsatellite <strong>in</strong>stability. Science. 1995;268(5215):1336–8.46. Ramp<strong>in</strong>o N, Yamamoto H, Io<strong>no</strong>v Y, Li Y, Sawai H, Reed JC, Perucho M. Somaticframeshift mutations <strong>in</strong> the BAX gene <strong>in</strong> colon cancers of the microsatellitemutator phe<strong>no</strong>type. Science. 1997;275(5302):967–9.47. Souza RF, Appel R, Y<strong>in</strong> J, Wang S, Smol<strong>in</strong>ski KN, Abraham JM, Zou TT, ShiYQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, FrazierM, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ. Microsatel-245
- Page 1 and 2:
Novel genetic and epigenetic altera
- Page 3 and 4:
TABLE OF CONTENTSACKNOWLEDGEMENTS .
- Page 5 and 6:
ACKNOWLEDGEMENTSThe present work ha
- Page 7 and 8:
Prefacetechnology[3]. This new tech
- Page 10 and 11:
SummaryThe subgroup of carcinomas w
- Page 12 and 13:
Introduction“Epigenetic inheritan
- Page 14 and 15:
Introductionamino acid change it is
- Page 16 and 17:
Introductionmethylation during embr
- Page 18 and 19:
IntroductionDNA is most of the time
- Page 20 and 21:
IntroductionFigure 5. DNA methylati
- Page 22 and 23:
IntroductionFigure 6. Incidence rat
- Page 24 and 25:
IntroductionFigure 8. Tumor staging
- Page 26 and 27:
Introductioninasmuch as 80% of colo
- Page 28 and 29:
IntroductionInstabilities involved
- Page 30 and 31:
Introductionthere seems to be a fid
- Page 32 and 33:
Introductionsevere alterations are
- Page 34 and 35:
Introductionpopulation-wide screeni
- Page 36 and 37:
IntroductionFigure 12. Present and
- Page 38 and 39:
RESULTS IN BRIEFPaper Ia. “DNA hy
- Page 40 and 41:
Results in Briefinstability, and se
- Page 42 and 43:
Results in BriefUnivariate survival
- Page 44 and 45:
Discussionseveral factors, and full
- Page 46 and 47:
Discussionlow threshold, we increas
- Page 48 and 49:
DiscussionIt may seem like unnecess
- Page 50 and 51:
Discussionthan 96% DHPLC do not sta
- Page 52 and 53:
DiscussionFigure 13. Mutation detec
- Page 54 and 55:
DiscussionClinical impact of molecu
- Page 56 and 57:
Discussionmarkers with a very high
- Page 58 and 59:
Discussionchromosomes in metaphase[
- Page 60 and 61:
DiscussionThese examples underline
- Page 62 and 63:
Discussiongenes. One is based on mu
- Page 64 and 65:
CONCLUSIONSWe have identified novel
- Page 66 and 67:
Future PerspectivesMolecular risk a
- Page 68 and 69:
REFERENCES1. Breasted J (1930) The
- Page 70 and 71:
References29. Deng G, Chen A, Pong
- Page 72 and 73:
References57. Al-Sukhni W, Aronson
- Page 74 and 75:
References84. Kunkel TA (1993) Nucl
- Page 76 and 77:
ReferencesLeggett B, Levine J, Kim
- Page 78 and 79:
References133. Lind GE, Thorstensen
- Page 80 and 81:
References156. Meling GI, Lothe RA,
- Page 82 and 83:
ReferencesT, Song X, Day RH, Sledzi
- Page 84 and 85:
References196. Honda S, Haruta M, S
- Page 86 and 87:
ORIGINAL ARTICLESAPPENDIXAppendix I
- Page 89 and 90:
GASTROENTEROLOGY 2007;132:1631-1639
- Page 91:
Paper IbGuro E Lind, Terje Ahlquist
- Page 94 and 95:
Journal of Translational Medicine 2
- Page 96 and 97:
Journal of Translational Medicine 2
- Page 98 and 99:
Journal of Translational Medicine 2
- Page 100 and 101:
Journal of Translational Medicine 2
- Page 102 and 103:
Journal of Translational Medicine 2
- Page 105:
Paper IITerje Ahlquist, Guro E Lind
- Page 108 and 109:
BackgroundMost cases of colorectal
- Page 110 and 111:
ADAMTS1 CDKN2A CRABP1 HOXA9 MAL MGM
- Page 112 and 113:
pseudogene, leading to a high rate
- Page 114 and 115:
strands. Proc Natl Acad Sci U S A 1
- Page 116 and 117:
concomitant absence of transcript a
- Page 119 and 120:
Volume 10 Number 7 July 2008 pp. 68
- Page 121 and 122:
682 RAS Signaling in Colorectal Car
- Page 123 and 124:
684 RAS Signaling in Colorectal Car
- Page 125 and 126:
686 RAS Signaling in Colorectal Car
- Page 127: Table W2. Detailed Somatic Events o
- Page 131 and 132: Identification of RCC2 as a prognos
- Page 133 and 134: INTRODUCTIONMicrosatellite instabil
- Page 135 and 136: unselected series of primary tumors
- Page 137 and 138: specificity, i.e. that they only am
- Page 139 and 140: On the assumption that DNA repair a
- Page 141 and 142: In order to ensure that gene mutati
- Page 143 and 144: Figure 2. Mutation frequency differ
- Page 145 and 146: and TAF1B (0.50), ACVR2A and ASTE1
- Page 147 and 148: Multivariate analysesA multivariate
- Page 149 and 150: When comparing our findings of muta
- Page 151 and 152: The test series included a low numb
- Page 153 and 154: entering M-phase remains to be seen
- Page 155 and 156: 12. Duval A, Reperant M, Hamelin R
- Page 157 and 158: 34. Martineau-Thuillier S, Andreass
- Page 159: AppendicesAppendix I:List of abbrev
- Page 163 and 164: Critical Reviews TM in Oncogenesis,
- Page 165 and 166: TARGET GENES OF MSI COLORECTAL CANC
- Page 167 and 168: TARGET GENES OF MSI COLORECTAL CANC
- Page 169 and 170: TARGET GENES OF MSI COLORECTAL CANC
- Page 171 and 172: TARGET GENES OF MSI COLORECTAL CANC
- Page 173 and 174: TARGET GENES OF MSI COLORECTAL CANC
- Page 175 and 176: TARGET GENES OF MSI COLORECTAL CANC
- Page 177: TARGET GENES OF MSI COLORECTAL CANC
- Page 181 and 182: TARGET GENES OF MSI COLORECTAL CANC
- Page 183 and 184: TARGET GENES OF MSI COLORECTAL CANC
- Page 185 and 186: TARGET GENES OF MSI COLORECTAL CANC
- Page 187 and 188: TARGET GENES OF MSI COLORECTAL CANC
- Page 189 and 190: TARGET GENES OF MSI COLORECTAL CANC
- Page 191: TARGET GENES OF MSI COLORECTAL CANC